Presentation Title: Pre-Award Activities Contract: Budgeting for Clinical Trials
Presented by Melissa L. Archer
Learning Goals
Compliance with Medicare Secondary Payer Act
Federal Anti-Kickback Laws – Budget Development
Medicare Coverage Analysis
Essential Terms in Clinical Trial Agreements
Driving Legal Concerns
At USC, trials must be compliant of Medicare Secondary Payor Act (“MSP”)
Expenses such as what will not be covered by private insurance and Medicare must be covered by the sponsor
Federal Anti-Kickback Laws/Stark Laws
Fair market value
No discounts! The data needs to look clean.
No endorsements for free supply of medications
Safe Harbors: Everything must be outlined and written in a contract
Sunshine Act--- it is the responsibility of the sponsors to gather, organize, and interpret this information; objective- transparency
Budgeting and Contracting
Budgeting Tools: Standardized Fees
Fixed Start-Up Fees
Fixed IRB Fees
Research (CPT) Fees
Research (Non-CPT) Fees
Elements of a Sponsored Research Agreement
Confidential Information
Patent Privacy and Use of Protected Health Information
Study Data
Publication
Protection of Inventions
Identification
Subject Injury Reimbursement
Budget and Payment Schedule
Final Take-Aways
Research must be fully costed
Agreement should cover all essential elements
Early PI participation is important for a quick start of study
Understand confidentiality obligations
Presentation Title: Managing Study Set-Up Logistics: Study Drug, Specimen, Space
Presented by Diana Palma BS, CCRP and Regina Olivas, RN, BSN, MSW
Logistical Considerations
Storage of Research Charts
Feasibility of the Study
Required Training specific to the protocol
Who is the sponsor?
Data Entry Systems--- which system can used for which function? (ex. A particular system may store data only while another stores patient info etc.)
Organizing Research Charts
Is there a study drug involved?
IRB Approval
Feasibility
Determined by PI and research team
Bring up protocol, location, staff, or technical concerns early on
Anticipated study enrollment expectations reviewed by all study staff
Reaching out to Ancillary Services: Radiology, pharmacy, lab
To ensure that protocol procedures fall within institutional scope of practice
Staff In-services/Education
Tailor presentations to audiences ie. Clerical staff vs. clinical nurses and physicians
Performed by PI, CRC
Additional services should be performed with study protocol amendments and inform all staff
Study Drug Management
Involve the Investigational Drug (ID) Pharmacy
ID Pharmacy can help with regulatory compliance integrity of blinding, preventing of errors involving drug study, dispensing the drug in timely fashion etc.
Specimen Storage & Handling
Following topics are presented by Regina Olivas, RN, BSN, MSW
Collaborate with lab and pathology
Where will your specimens be stored and how to be handled?
Need for refrigerators and freezers
Assess equipment ie. Centrifuges and training on how to use equipment
No Space may result in Off-site locations
Make sure that shipping specimens are shipped in a timely manner and consider weather conditions of journey and final destination
Space Considerations
Research files should be in lockable file cabinets
Access to study staff workstation, research supply, and study drug
Monitor Site Visits
May be a few individuals or a whole team
Need a private work space for routine visits
Record Storage: Ongoing Studies
Central location with the documentation
All research charts should be accessible in case of audit
Creating Standard Operating Procedure (SOP)
Record Storage: Closed Studies
Check with institutional policies before moving or discarding research records
ex. Cancer studies are ongoing -> research concerning cancer should be maintained
Conclusion
Acknowledgement
Accompanying text created
by Annie Ly | Undergraduate Research Associate and Provost's First Generation
Research Fellow | lyannie@usc.edu
NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI
resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.